NCT06419894

Advanced Cardiac Magnetic Resonance Imaging for Assessment of Obstructive Coronary Artery Disease: ADVOCATE-CMR

Amsterdam UMC, location VUmc·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Coronary Artery Disease
Study type
Observational
Sponsor & location
Primary sponsor
Amsterdam UMC, location VUmc
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2033
Enrollment
182 participants
Primary outcome

Diagnostic accuracy of QP CMR (stress myocardial blood flow [MBF], stress relative MBF [rMBF], myocardial perfusion reserve [MPR] and relative MPR [rMPR]) to detect obstructive CAD, as defined by FFR

Summary

Stress perfusion cardiovascular magnetic resonance (CMR) imaging is an established
 non-invasive imaging test for detection of obstructive coronary artery disease (CAD). Fully
 automated quantitative perfusion CMR (QP CMR) is a new technical advancement, which offers
 measurement of myocardial blood flow in CMR. Additionally, recent innovations have introduced
 various contrast-agent-free methods for CAD assessment, such as stress T1 mapping reactivity
 (∆T1) and oxygen-sensitive CMR (OS CMR). These methods might eliminate the necessity for
 contrast administration in clinical practice, simplifying, reducing time, invasiveness and
 costs in evaluating patients with suspected obstructive CAD. The ADVOCATE-CMR study aims to
 validate QP CMR, ∆T1 and OS CMR imaging against invasive fractional flow reserve (FFR) for
 detection of obstructive CAD. The study also aims to head-to-head compare the diagnostic
 accuracy of these CMR techniques with the conventional visual assessment of stress perfusion
 CMR and to correlate them to short- and long-term clinical outcomes.

ICD-10 classifications
Cardiovascular disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart diseaseAbnormal findings on diagnostic imaging of heart and coronary circulationCoronary vasodilators, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06419894
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06419894 through Pure Global AI's free database. This phase not specified trial is sponsored by Amsterdam UMC, location VUmc and is currently Not yet recruiting. The study focuses on Coronary Artery Disease. Target enrollment is 182 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.